Status:

COMPLETED

Metabolism of Nicotine and Cotinine in Pregnant African-American Women

Lead Sponsor:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Pregnancy

Smokers

Eligibility:

FEMALE

18-30 years

Phase:

PHASE1

Brief Summary

This study will provide information regarding the optimal dose and duration of nicotine replacement using the nicotine patch for a smoking cessation study of pregnant African-American women. Previous ...

Detailed Description

This is a two-part protocol. This protocol is for Part A, the specific aims of which are to: 1. Determine the optimal dose (21 mg or 14 mg) and duration (24 hours or 16 hours) of nicotine replacement...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • English-speaking, self-identified African-American women smokers, age 18 to 30 years, with singleton, uncomplicated pregnancies in the second trimester will be eligible.
  • Only women receiving routine prenatal care, begun by 16 weeks gestation, will be included.
  • Women will be asked to release records of their pregnancy to study staff for review prior to enrollment.
  • All participating women will receive clearance from their obstetrician before enrollment.
  • EXCLUSION CRITERIA:
  • Women who report use of any other substance of abuse besides nicotine will be ineligible.

Exclusion

    Key Trial Info

    Start Date :

    January 6 2005

    Trial Type :

    INTERVENTIONAL

    End Date :

    December 1 2006

    Estimated Enrollment :

    50 Patients enrolled

    Trial Details

    Trial ID

    NCT00341640

    Start Date

    January 6 2005

    End Date

    December 1 2006

    Last Update

    July 2 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institute of Child Health and Human Development (NICHD)

    Bethesda, Maryland, United States, 20892